Susquehanna International Group
ASMB icon

Susquehanna International Group’s Assembly Biosciences ASMB Stock Holding History

Susquehanna International Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$914K Sell
32,949
-47,445
-59% -$1.35M ﹤0.01% 8113
2025
Q4 		$2.73M Sell
80,394
-50,632
-39% -$1.63M ﹤0.01% 5043
2025
Q3 		$3.35M Buy
+131,026
New +$2.87M ﹤0.01% 4762
2025
Q2 		– Sell
-17,414
Closed -$166K – 12607
2025
Q1 		$166K Sell
17,414
-4,040
-19% -$52.8K ﹤0.01% 11123
2024
Q4 		$339K Buy
21,454
+5,597
+35% +$90.1K ﹤0.01% 9566
2024
Q3 		$240K Sell
15,857
-1,543
-9% -$23.5K ﹤0.01% 10098
2024
Q2 		$239K Buy
+17,400
New +$248K ﹤0.01% 9967
2024
Q1 		– Sell
-5,981
Closed -$58.9K – 12124
2023
Q4 		$58.9K Buy
+5,981
New +$56.9K ﹤0.01% 11647
2023
Q3 		– Sell
-1,006
Closed -$13.9K – 11973
2023
Q2 		$13.9K Sell
1,006
-425
-30% -$5.22K ﹤0.01% 11712
2023
Q1 		$14.4K Sell
1,431
-340
-19% -$5.74K ﹤0.01% 12131
2022
Q4 		$27.6K Buy
1,771
+718
+68% +$12.3K ﹤0.01% 11649
2022
Q3 		$21K Sell
1,053
-277
-21% -$6.7K ﹤0.01% 12582
2022
Q2 		$34K Sell
1,330
-2,301
-63% -$53K ﹤0.01% 12158
2022
Q1 		$90K Sell
3,631
-1,119
-24% -$24K ﹤0.01% 11977
2021
Q4 		$133K Buy
4,750
+1,759
+59% +$57.7K ﹤0.01% 11926
2021
Q3 		$125K Sell
2,991
-3,716
-55% -$156K ﹤0.01% 11920
2021
Q2 		$312K Buy
6,707
+3,902
+139% +$193K ﹤0.01% 10698
2021
Q1 		$155K Sell
2,805
-411
-13% -$27.2K ﹤0.01% 11628
2020
Q4 		$234K Sell
3,216
-592
-16% -$69.5K ﹤0.01% 9777
2020
Q3 		$751K Buy
+3,808
New +$959K ﹤0.01% 6802
2020
Q2 		– Sell
-850
Closed -$198K – 10084
2020
Q1 		$151K Buy
+850
New +$182K ﹤0.01% 8988
2019
Q4 		– Sell
-9,391
Closed -$1.73M – 9673
2019
Q3 		$1.11M Sell
9,391
-5,082
-35% -$769K ﹤0.01% 5476
2019
Q2 		$2.34M Buy
+14,473
New +$2.75M ﹤0.01% 3878
2019
Q1 		– Sell
-4,279
Closed -$1.08M – 8772
2018
Q4 		$1.16M Sell
4,279
-3,200
-43% -$926K ﹤0.01% 4404
2018
Q3 		$3.33M Sell
7,479
-2,094
-22% -$981K ﹤0.01% 3212
2018
Q2 		$4.5M Buy
9,573
+3,752
+64% +$1.98M ﹤0.01% 2846
2018
Q1 		$3.43M Buy
5,821
+3,580
+160% +$2.22M ﹤0.01% 3046
2017
Q4 		$1.22M Sell
2,241
-1,349
-38% -$611K ﹤0.01% 4849
2017
Q3 		$1.5M Sell
3,590
-5,570
-61% -$1.71M ﹤0.01% 4456
2017
Q2 		$2.27M Sell
9,160
-1,933
-17% -$544K ﹤0.01% 3691
2017
Q1 		$3.39M Buy
11,093
+8,475
+324% +$2.08M ﹤0.01% 2847
2016
Q4 		$382K Buy
2,618
+1,391
+113% +$207K ﹤0.01% 7511
2016
Q3 		$106K Sell
1,227
-817
-40% -$63.1K ﹤0.01% 7912
2016
Q2 		$136K Buy
+2,044
New +$134K ﹤0.01% 7869
2014
Q3 		– Sell
-540
Closed -$42K – 9391
2014
Q2 		$42K Buy
540
+146
+37% +$10.4K ﹤0.01% 9615
2014
Q1 		$30K Buy
+394
New +$61.4K ﹤0.01% 8759
2013
Q4 		– Sell
-509
Closed -$92.7K – 8947
2013
Q3 		$88K Buy
+509
New +$78K ﹤0.01% 8117

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Susquehanna International Group's ASMB Position: Q1 2026 in Review

Susquehanna International Group reduced its Assembly Biosciences (ASMB) stake by 59% in Q1 2026, selling an estimated $1.35M and leaving 32,949 shares worth $914K. The position accounts for ﹤0.01% of the portfolio, ranked #8113.

Susquehanna International Group first reported a position in ASMB in Q3 2013 and has held it in 37 quarters since. The position peaked at $4.5M in Q2 2018. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Susquehanna International Group held 32,949 shares of Assembly Biosciences worth $914K as of Q1 2026.
  • Susquehanna International Group sold 47,445 Assembly Biosciences shares in Q1 2026, an estimated $1.35M.
  • Assembly Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8113 holding.
  • Susquehanna International Group first reported a position in Assembly Biosciences in Q3 2013 and has held it in 37 quarters since.
  • Susquehanna International Group's Assembly Biosciences position peaked at $4.5M in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.